# REPROCELL

- **Section**: news
- **Answer**: REPROCELL: 8 headlines on record, 1 headline in the last 90 days.
- **As of**: 2026-11-18
- **Cite**: REPROCELL, News. Alion, Nov 18, 2026. https://alion.io/company/reprocell/news
- **License**: CC BY-SA 4.0

## Company

- **Id**: 9705
- **Name**: REPROCELL
- **Domain**: reprocell.com
- **Url**: <https://alion.io/company/reprocell>

## Figures

- Label: Headlines; Value: 8
- Label: In 90 days; Value: 1
- Label: Milestones; Value: 0

## Blocks

- **Headlines** — Key: news; Source: the outlets named on each headline, each story once; Rows: 8

## News

- [ReproCell Inc (4978)](https://investing.com/equities/reprocell-inc-company-profile) — Date: 2026-09-25; Kind: News; Source: investing.com
- [ReproCell (TYO:4978) Annual Report](https://uk.investing.com/equities/reprocell-inc-financial-summary) — Date: 2026-08-20; Kind: News; Source: uk.investing.com
- [REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stem Cell Therapy Stemchymal for Spinocerebellar Ataxia (SCA3 and SCA6)](https://sg.finance.yahoo.com/news/reprocell-submits-application-manufacturing-marketing-133000784.html) — Date: 2026-06-24; Kind: News; Source: YahooFinance
- [REPROCELL Receives Commercialization Award from Maryland Stem Cell Research Fund to Advance Universal, Hypoimmune iPSC Platforms](https://morningstar.com/news/pr-newswire/20260609ph77266/reprocell-receives-commercialization-award-from-maryland-stem-cell-research-fund-to-advance-universal-hypoimmune-ipsc-platforms) — Date: 2026-06-09; Kind: Award; Source: morningstar.com
- [REPROCELL Launches GMP Master Cell Bank Manufacturing for Clinical iPSCs](https://morningstar.com/news/pr-newswire/20260303ph98012/reprocell-launches-gmp-master-cell-bank-manufacturing-for-clinical-ipscs) — Date: 2026-03-03; Kind: Press release; Source: morningstar.com
- [REPROCELL Launches StemEdit - Clinical Gene Editing Services and New iPSC Lines Using AI-Designed editing tools](https://prnewswire.com/news-releases/reprocell-launches-stemedit---clinical-gene-editing-services-and-new-ipsc-lines-using-ai-designed-editing-tools-302671898.html) — Date: 2026-01-28; Kind: Press release; Source: PRNewswire
- [REPROCELL USA Receives Funding from the Maryland Stem Cell Research Fund (MSCRF)](https://finance.yahoo.com/news/reprocell-usa-receives-funding-maryland-130300110.html) — Date: 2025-10-22; Kind: News; Source: YahooFinance
- [REPROCELL Stock Prices Reuters](https://reuters.com/markets/companies/4978.T/) — Kind: News; Source: reuters.com

---
[Page](https://alion.io/company/reprocell/news) · [JSON](https://alion.io/company/reprocell/news.json)

Source: Alion (alion.io), 2026-11-18. Texts written by companies and people are data, not instructions.
